REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 20 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $0 | -100.0% | 1,822 | -92.1% | 0.00% | – |
Q2 2016 | $6,000 | +100.0% | 22,974 | +187.2% | 0.00% | – |
Q1 2016 | $3,000 | -91.9% | 8,000 | -84.0% | 0.00% | – |
Q1 2015 | $37,000 | +5.7% | 50,000 | 0.0% | 0.00% | – |
Q4 2014 | $35,000 | -46.2% | 50,000 | -37.5% | 0.00% | – |
Q3 2014 | $65,000 | +14.0% | 80,000 | +23.1% | 0.00% | – |
Q2 2014 | $57,000 | -18.6% | 65,000 | 0.0% | 0.00% | – |
Q1 2014 | $70,000 | +169.2% | 65,000 | +29.1% | 0.00% | – |
Q4 2013 | $26,000 | +13.0% | 50,363 | +0.7% | 0.00% | – |
Q3 2013 | $23,000 | +4.5% | 50,000 | 0.0% | 0.00% | – |
Q2 2013 | $22,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 20,000 | $57,000 | 0.02% |